symbol,statement_type,period_end,line_item,value
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Treasury Shares Number,884410.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Ordinary Shares Number,158396729.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Share Issued,159281139.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Debt,13486000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Debt,27310000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tangible Book Value,26172000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Invested Capital,86918000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Working Capital,14126000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net Tangible Assets,26172000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Lease Obligations,2941000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock Equity,62549000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Capitalization,84052000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Equity Gross Minority Interest,62386000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Minority Interest,-163000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Stockholders Equity,62549000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Equity Interest,62391000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Retained Earnings,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Additional Paid In Capital,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Capital Stock,158000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Common Stock,158000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Liabilities Net Minority Interest,65178000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,43532000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Liabilities,11375000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Tradeand Other Payables Non Current,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Revenue,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Liabilities,1722000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,23888000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Capital Lease Obligation,2385000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Debt,21503000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Provisions,1191000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Liabilities,21646000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Liabilities,2021000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt And Capital Lease Obligation,3422000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Capital Lease Obligation,556000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Debt,2866000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Provisions,784000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Payables,10232000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Payable,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Dividends Payable,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Tax Payable,184000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Payable,10048000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Assets,127564000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Total Non Current Assets,91792000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Non Current Assets,198000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Prepaid Assets,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Non Current Deferred Taxes Assets,2574000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentin Financial Assets,626000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Available For Sale Securities,626000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Long Term Equity Investment,75000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Investmentsin Associatesat Cost,75000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill And Other Intangible Assets,36377000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Intangible Assets,10967000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Goodwill,25410000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Net PPE,51682000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accumulated Depreciation,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross PPE,51682000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Construction In Progress,27147000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Properties,24535000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Machinery Furniture Equipment,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Buildings And Improvements,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Land And Improvements,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Properties,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Current Assets,35772000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Current Assets,2206000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Assets Held For Sale Current,675000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Restricted Cash,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Prepaid Assets,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Inventory,11292000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Inventories,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Finished Goods,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Work In Process,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Raw Materials,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Receivables,11000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Taxes Receivable,180000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Accounts Receivable,8915000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Gross Accounts Receivable,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,12493000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Other Short Term Investments,1610000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash And Cash Equivalents,10883000000.0
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Equivalents,
JUBLPHARMA.NS,balance_sheet,2025-03-31 00:00:00,Cash Financial,
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Treasury Shares Number,930402.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Ordinary Shares Number,158350737.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Share Issued,159281139.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Debt,24602000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Debt,36640000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tangible Book Value,19267000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Invested Capital,88480000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Working Capital,19871000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net Tangible Assets,19267000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Lease Obligations,2499000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock Equity,54339000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Capitalization,86010000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Equity Gross Minority Interest,54211000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Minority Interest,-128000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Stockholders Equity,54339000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Equity Interest,145000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Retained Earnings,45397000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Additional Paid In Capital,398000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Capital Stock,158000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Common Stock,158000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Liabilities Net Minority Interest,61274000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,42384000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Liabilities,5438000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Tradeand Other Payables Non Current,188000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Revenue,5438000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Liabilities,2108000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,33649000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Capital Lease Obligation,1978000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Debt,31671000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Provisions,1001000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Liabilities,18890000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Liabilities,1632000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt And Capital Lease Obligation,2991000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Capital Lease Obligation,521000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Debt,2470000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Provisions,664000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Payables,14237000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Payable,5279000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Dividends Payable,25000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Tax Payable,370000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Payable,8563000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Assets,115485000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Total Non Current Assets,76724000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Non Current Assets,8000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Prepaid Assets,1776000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Non Current Deferred Taxes Assets,2327000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentin Financial Assets,344000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Available For Sale Securities,322000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,22000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Long Term Equity Investment,78000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Investmentsin Associatesat Cost,78000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill And Other Intangible Assets,35072000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Intangible Assets,10433000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Goodwill,24639000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Net PPE,36871000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accumulated Depreciation,-19972000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross PPE,56843000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Construction In Progress,12523000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Properties,24348000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Machinery Furniture Equipment,32898000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Buildings And Improvements,10543000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Land And Improvements,879000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Properties,0.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Current Assets,38761000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Current Assets,10000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Assets Held For Sale Current,2439000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Restricted Cash,29000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Prepaid Assets,1085000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Inventory,12896000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Inventories,
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Finished Goods,3267000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Work In Process,3500000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Raw Materials,6129000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Receivables,3350000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Taxes Receivable,167000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Accounts Receivable,9159000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-668000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Gross Accounts Receivable,9827000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,9626000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Other Short Term Investments,87000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash And Cash Equivalents,9539000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Equivalents,519000000.0
JUBLPHARMA.NS,balance_sheet,2024-03-31 00:00:00,Cash Financial,9020000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Treasury Shares Number,209457.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Ordinary Shares Number,159071682.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Share Issued,159281139.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Debt,23993000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Debt,36768000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tangible Book Value,20197000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Invested Capital,88094000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Working Capital,19900000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net Tangible Assets,20197000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Lease Obligations,2667000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock Equity,53993000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Capitalization,85097000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Equity Gross Minority Interest,53918000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Minority Interest,-75000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Stockholders Equity,53993000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Equity Interest,62000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Retained Earnings,45368000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Additional Paid In Capital,398000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Capital Stock,159000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Common Stock,159000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Liabilities Net Minority Interest,57649000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,39925000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Liabilities,2685100000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Tradeand Other Payables Non Current,19000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Revenue,2685000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Liabilities,3062000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,33237000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Capital Lease Obligation,2133000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Debt,31104000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Provisions,922000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Liabilities,17724000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Liabilities,1217800000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt And Capital Lease Obligation,3531000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Capital Lease Obligation,534000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Debt,2997000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Provisions,783000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Payables,12691000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Payable,3823000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Dividends Payable,31000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Tax Payable,624000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Payable,8213000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Assets,111567000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Total Non Current Assets,73943000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Non Current Assets,9000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Prepaid Assets,1133000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Non Current Deferred Taxes Assets,2275000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentin Financial Assets,328000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Available For Sale Securities,308000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,20000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Long Term Equity Investment,2236000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Investmentsin Associatesat Cost,2236000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill And Other Intangible Assets,33796000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Intangible Assets,9510000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Goodwill,24286000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Net PPE,33652000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accumulated Depreciation,-15176000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross PPE,48828000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Construction In Progress,7733000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Properties,25918700000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Machinery Furniture Equipment,29425000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Buildings And Improvements,10807000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Land And Improvements,863000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Properties,0.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Current Assets,37624000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Current Assets,56000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Assets Held For Sale Current,0.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Restricted Cash,35000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Prepaid Assets,1379000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Inventory,13805000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Inventories,12590000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Finished Goods,2945000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Work In Process,4534000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Raw Materials,6326000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Receivables,2469000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Taxes Receivable,116000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Accounts Receivable,9612000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-505000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Gross Accounts Receivable,10117000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,10152000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Other Short Term Investments,44000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash And Cash Equivalents,10108000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Equivalents,180000000.0
JUBLPHARMA.NS,balance_sheet,2023-03-31 00:00:00,Cash Financial,9928000000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Treasury Shares Number,
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Ordinary Shares Number,159281139.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Share Issued,159281139.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Debt,19473530000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Debt,31920020000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tangible Book Value,21494860000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Invested Capital,82461790000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Working Capital,19175910000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net Tangible Assets,21494860000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Lease Obligations,2643860000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock Equity,53185630000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Capitalization,77828050000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Equity Gross Minority Interest,53164000000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Minority Interest,-21630000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Stockholders Equity,53185630000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Equity Interest,36630000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Retained Earnings,46850170000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Additional Paid In Capital,398360000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Capital Stock,159190000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Common Stock,159190000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Liabilities Net Minority Interest,46744670000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,30828660000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Liabilities,73000000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Tradeand Other Payables Non Current,5040000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Revenue,72960000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Liabilities,3029650000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,26764350000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Capital Lease Obligation,2121930000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Debt,24642420000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Provisions,956660000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Liabilities,15916010000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Liabilities,1518600000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt And Capital Lease Obligation,5155670000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Capital Lease Obligation,521930000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Debt,4633740000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Provisions,868390000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Payables,8979440000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Payable,2921420000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Dividends Payable,35560000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Tax Payable,345060000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Payable,5677400000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Assets,99908670000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Total Non Current Assets,64816750000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Non Current Assets,9460000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Prepaid Assets,1056680000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Non Current Deferred Taxes Assets,1612710000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentin Financial Assets,434930000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Available For Sale Securities,369270000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,65660000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Long Term Equity Investment,1951070000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Investmentsin Associatesat Cost,1951070000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill And Other Intangible Assets,31690770000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Intangible Assets,9263230000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Goodwill,22427540000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Net PPE,27910990000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accumulated Depreciation,-12400970000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross PPE,40311960000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Construction In Progress,2918260000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Properties,24992800000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Machinery Furniture Equipment,26300470000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Buildings And Improvements,10218100000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Land And Improvements,875130000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Properties,0.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Current Assets,35091920000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Current Assets,32940000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Assets Held For Sale Current,
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Restricted Cash,39740000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Prepaid Assets,1188510000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Inventory,12548690000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Inventories,13380000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Finished Goods,3146060000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Work In Process,3792580000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Raw Materials,5596670000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Receivables,2144100000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Taxes Receivable,1840000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Accounts Receivable,9279940000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-258790000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Gross Accounts Receivable,9538730000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,9856160000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Other Short Term Investments,53530000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash And Cash Equivalents,9802630000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Equivalents,290760000.0
JUBLPHARMA.NS,balance_sheet,2022-03-31 00:00:00,Cash Financial,9511870000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Treasury Shares Number,107140.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Ordinary Shares Number,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Share Issued,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Debt,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Debt,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tangible Book Value,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Invested Capital,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Working Capital,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net Tangible Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Lease Obligations,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock Equity,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Capitalization,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Equity Gross Minority Interest,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Minority Interest,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Stockholders Equity,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Equity Interest,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Retained Earnings,43177110000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Additional Paid In Capital,398360000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Capital Stock,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Common Stock,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Liabilities Net Minority Interest,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Liabilities Net Minority Interest,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Liabilities,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Tradeand Other Payables Non Current,194500000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Revenue,75710000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Liabilities,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt And Capital Lease Obligation,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Capital Lease Obligation,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Debt,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Provisions,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Liabilities,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Liabilities,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt And Capital Lease Obligation,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Capital Lease Obligation,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Debt,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Provisions,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Payables,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Payable,2628710000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Dividends Payable,40220000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Tax Payable,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Payable,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Total Non Current Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Non Current Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Prepaid Assets,539700000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Non Current Deferred Taxes Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentin Financial Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Available For Sale Securities,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Financial Assets Designatedas Fair Value Through Profitor Loss Total,91530000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Long Term Equity Investment,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Investmentsin Associatesat Cost,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill And Other Intangible Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Intangible Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Goodwill,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Net PPE,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accumulated Depreciation,-9928300000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross PPE,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Construction In Progress,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Properties,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Machinery Furniture Equipment,22095390000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Buildings And Improvements,9937620000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Land And Improvements,869420000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Properties,0.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Current Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Current Assets,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Assets Held For Sale Current,0.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Restricted Cash,102190000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Prepaid Assets,977880000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Inventory,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Inventories,11470000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Finished Goods,2755390000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Work In Process,3472200000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Raw Materials,5054750000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Receivables,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Taxes Receivable,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Accounts Receivable,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Allowance For Doubtful Accounts Receivable,-219810000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Gross Accounts Receivable,8418850000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Cash Equivalents And Short Term Investments,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Other Short Term Investments,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash And Cash Equivalents,
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Equivalents,221210000.0
JUBLPHARMA.NS,balance_sheet,2021-03-31 00:00:00,Cash Financial,4758140000.0
